Table 3.
Sr. No. | Nanoparticles (NPs) | Capping Agent | Effect of Capping Agent | Bioimaging Application | Reference |
---|---|---|---|---|---|
1. | CdS QDs | Dextrin | Reduced toxicity of innate cadmium sulfide (CdS) | Used as fluorescent agent in in vitro and in vivo studies where maximum fluorescence was observed in kidney, liver, and brain | [151] |
2. | Au NPs & DTA | Polyamidoamine (PAMAM) dendrimer | Improved X-ray attenuation, stability, biocompatibility, and enhanced blood circulation time | CT Imaging | [152] |
3. | Bimetallic Au-Ag NPs | Folic acid (FA)-modified PAMAM dendrimer | 25% higher X-ray attenuation than Omnipaque. In in vitro better CT imaging of cancer cells overexpressing FA receptors showed 2.3 to 2.7-fold higher uptake than the cells possessing low level of FA expression. |
In vitro CT imaging in cancer cells | [153] |
4. | Ag NPs | Acetylated-PAMAM dendrimer | Extended blood circulation time led to prolonged enhancement | X-ray CT contrast agent | [154] |
5. | Au NPs | Acetylated-PAMAM dendrimer | Improved biocompatibility, 1.6 times higher X-ray attenuation compared to Omnipaque, specific targeting through receptor-mediated endocytosis | In vivo CT imaging | [155] |
6. | Au NPs | Thiolated PEG & pluronic triblock copolymer (PEO–PPO–PEO) | Improved colloidal and optical stability and biocompatibility | Used as scattering probes for dark-field imaging of cancer cells under both in vitro and in vivo conditions | [156] |
7. | Gd2O3 & PMNPs | Diethylene glycol polymer & Liposomes | No in vitro cytotoxic effects, sensitive contrast agent | MRI contrast agent and marker for cell tracking | [157] |
8. | IONPs | Dextran | Biocompatible, superior T2 relaxation rate and high relaxivities led to clear distinguished signal imaging intensity of specific organ, tumor, and whole-body | MRI contrast agents | [158] |
9. | Au NPs | Poly di(carboxylatophenoxy)phosphazene | Biocompatible and biodegradable | Can be used as contrast agents for photoacoustic imaging | [159] |
10. | INPs | PEG | Biocompatible, extended high contrast vascular imaging and stability, selectively accumulated in tumor | Vascular and tumor imaging by Micro-CT | [160] |
11. | Iodine-131 labeled Au NPs | Polyethyleneimine (PEI) | Improved X-ray attenuation coefficient, colloidal stability, cytocompatibility, and radiochemical stability in vitro | Single-photon emission computed tomography/computed tomography (SPECT/CT) imaging and radionuclide therapy | [161] |
12. | Bi2S3 NPs & QDs | PEG-phospholipid bilayer | Enhanced CT contrast and fluorescence imaging capability, longer circulation time (>4 h) than iobitridol, biocompatibility, and safety. | Used for combined CT/fluorescence imaging | [162] |
13. | Radioactive iodide-124 labeled Au NPs | PEG | Non-toxic, high stability, and sensitivity in various pH, serum, and in vivo conditions | In vivo tumor imaging through combined positron emission tomography and cerenkov luminescent imaging (PET/CLI). | [163] |
14. | CuS [c(RGDfK)] | PEG | High efficacy and minimal side effects | Promising platform for image guided ablation therapy | [164] |
15. | Au NPs | Glycol-chitosan | Simplest nanocomposite did not require antibodies or complex surface modification | Photoacoustic contrast agent | [165] |
16. | Silica NPs | PEG & doping with cyanine 5.5 (Cy5.5) & cyanine 7 (Cy7) dyes | High colloidal stability in water and in biological environment, with absorption and fluorescence emission in the NIR field | Used to achieve optical and photoacoustic imaging | [166] |
17. | Au NPs | Poly(perylene diimide) (PPDI) & PEG | Greater photothermal effect and a stronger photoacoustic signal | Used as photoacoustic (PA) agents under in vivo imaging and therapeutic evaluation | [167] |
18. | Plectin-SPION-Cy7 or SPION-Cy7 | DSPE-PEG-NH2 | Highly accumulated in tumor, MIAPaCa2 and XPA-1 carcinoma cells but not in normal pancreatic tissues, liver, and kidney | Optical imaging and MRI | [168] |
19. | Curcumin-Ag NPs complex | Polyvinylpyrrolidone (PVP) | Enhanced water solubility and bioavailability in a biological system without effecting its therapeutic potential. Fluorescence efficiency in cancer cellular medium is ∼2.37 times higher | Used as fluorescent probe in CT imaging | [169] |
20. | Au NPs doped with silver | Gelatin | Improved stability, quantum yield, and fluorescence lifetime. Remarkable biocompatibility | Promising approach for imaging in a challenging tissue as skin | [170] |
21. | MoO3 mixed with optoelectrochemically active dye complex (Ru(II)) | Chitosan (CS) | Biocompatible | Used in intracellular imaging | [171] |
22. | Au NPs | Zinnia elegans plant extract | Highly biocompatible and do not use any targeted ligand | Used as imaging agent in NIR region | [172] |
23. | Ag NPs | 4-mercaptobenzoic acid-capped | Enhanced fluorescent brightness, improved photostability, and low cytotoxicity | Used for simultaneous cellular imaging and photodynamic therapy |
[173] |
24. | N-doped fluorescent Si NPs with an ultra-high quantum yield | EDTA-2Na | Water dispersibility, higher stability, and biocompatibility | Used in cellular imaging | [174] |
25. | Carboxylated PPy-NPs | Folic acid functionalized carbon dots | Photostability, specific targeting, biocompatible | Used as PTT imaging agent | [175] |
Gold nanoparticles (Au NPs); cadmium sulfide quantum dots (CdS QDs); radiodense iodine-containing compound (DTA); silver nanoparticles (Ag NPs); gadolinium oxide (Gd2O3); paramagnetic nanoparticles (PMNPs); iron oxide nanoparticles (IONPs); iodine nanoparticles (INPs); bismuth sulfide (Bi2S3); quantum dots (QDs); copper sulfide (CuS); polyethylene glycol (PEG); cyclic RGDfK peptide (cRGDfK); 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine-N-amino(polyethylene glycol) (DSPE-PEG-NH2); superparamagnetic iron oxide (Fe3O4) nanoparticles (SPION) conjugated with plectin-1 antibody and Cy7 (Plectin-SPION-Cy7) (SPION-Cy7); Molybdenum trioxide (MoO3), Ruthenium(II)-bipyridine complex (Ru(II)), Ethylenediaminetetraacetic acid disodium salt (EDTA-2Na), Polypyrrole nanoparticles (PPy-NPs).